Re-classification of pancreatobiliary tumors by mucin expression profile - An application to the operative indication -
Re-classification of pancreatobiliary tumors by mucin expression profile - An application to the operative indication -
批准号:
12470046
负责人:
YONEZAWA Suguru
金额:
$8.64万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We examined the expression profiles of membrane mucins (MUC1 and MUC4) and secretory mucins (MUC2, MUC5AC and MUC6) hi many pancreatobiliary tumors, and compared the results with clinicopathological factors of the patients with those tumors.In pancreatic tumors, we examined mucins expression in invasive ductal carcinomas (IDCs) and intraductal papillary mucinous neoplasms (IPMNs) using immunohistochemistry and in situ hybridization. IPMNs were classified into two histological subtypes, "dark cell type (IPM N-D" and "clear cell type (IPMN-C). IDCs showed high expression of all the glycoforms of MUC1. IPMNs-D showed no or low expression of all the glycoforms of MUC1. IPMNs-C showed low expression of poorly glycosylated MUC1 (MUC1/DF3), but expression of glycosylated MUC1 (MUC1/HMFG-1). Expression of MUC2 was negative in IDC, high in IPMN-D and low in IPMN-C. MUC5AC was highly expressed in all the types. MUC6 expression was higher in IPMNs-C than in IDCs and IPMNs-D.In intrahepatic cholan … More giocarcinoma-mass forming type, MUC4 expression was a statistically significant independent risk factor. Mucin-producing bile duct tumors were classified into two distinct categories by the histopathological findings, morphometry and mucin expression profiles, and there was a significant difference of the survivals between the two patient groups with two different tumors. In the patients with extrahepatic bile duct carcinomas, MUC1/DF3 was the most useful prognosis indicator among the various glycoforms of MUC1 mucins. For the comparative studies with the pancreatobiliary tumors, we also studied expression profiles of mucins in the tumors of other organs such as colon, breast, etc.To investigate the expression mechanism of MUC2 in the tumors, we examined DNA methylation in promotor areas of MUC2 gene in pancreatic carcinoma cells with MUC2 + or - expression, using methylation specific PCR. The promotor area of MUC2 gene was unmethylated in pancreatic carcinoma calls with MUC2 + expression, whereas it was methylated in pancreatic carcinoma cells with MUC2 - expression. Expression mechanism of MUC2 in the pancreatic tumors may be regulated by DNA methylation in the promptor areas of MUC2 gene. We also could amplify DNA from a small amount of tissues obtained by microdissection. Less
期刊论文(95)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Wang, F., et al.: "Altered GalNAc-α-2, 6-sialylation compartments for mucin-associated sialyl-Tn antigen in colorectal adenoma and adenocarcinoma"The Journal of Histochemistry and Cytochemistry. 49・12. 1581-1592 (2001)
Wang, F., 等人:“结直肠腺瘤和腺癌中粘蛋白相关唾液酸 Tn 抗原的改变 GalNAc-α-2, 6-唾液酸化区室”《组织化学和细胞化学杂志》49·12。 2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wang, F., et al.: "Altered GalNAc-α-2,6-sialylation compartments for mucin-associated sialyl-Tn antigen in colorectal adenoma and adenocarcinoma"J. Histochem. Cytochem.. 49・12. 1581-1591 (2001)
Wang, F., et al.:“结直肠腺瘤和腺癌中粘蛋白相关唾液酸 Tn 抗原的改变 GalNAc-α-2,6-唾液酸化区室”J. Histochem.. 1581-1591( 2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Li, A., et al.: "Comparative study for histology, proliferative activity, glycoproteins, and p53 protein between old and recent colorectal adenomas in Japan"Cancer Lett.. 170(1). 45-52 (2001)
Li, A., 等人:“日本旧有和新近结直肠腺瘤的组织学、增殖活性、糖蛋白和 p53 蛋白的比较研究”Cancer Lett.. 170(1)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
米澤傑, 他: "ムチンの発現様式からみた通常型膵管癌の組織発生-膵管内乳頭腫瘍との対比-"胆と膵. 23・3. 187-194 (2002)
Suguru Yonezawa 等人:“基于粘蛋白表达模式的传统胰腺导管癌的组织发生 - 与导管内乳头状肿瘤的比较 -”Bile and Pancreas 23・3(2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Li,A.,Yonezawa,S., et al.: "Comparative study for histology, proliferative activity, glycoproteins, and p53 protein between old and recent colorectal adenomas in Japan"Cancer Letters. (印刷中).
Li, A., Yonezawa, S. 等人:“日本旧有和新近结直肠腺瘤的组织学、增殖活性、糖蛋白和 p53 蛋白的比较研究”《癌症快报》(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 36 条
Establishment of early diagnosis system of pancreatobiliary carcinomas by the application of mucin expression profiles
-
批准号:23390085
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.9万
-
财政年份:2011
-
负责人:YONEZAWA Suguru
-
依托单位:
Mucin gene expression mechanism related to a new classification of pancreatobiliary neoplasms
-
批准号:20590345
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:YONEZAWA Suguru
-
依托单位:
Expression of new cell-cell adhesion molecule and mucin genes in cancers : its relationship with invasion or metastasis of cancers
-
批准号:08457064
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.18万
-
财政年份:1996
-
负责人:YONEZAWA Suguru
-
依托单位:
Study of mechanism of mucin antigen expression which is related with prognosis of patients carrying cancer
-
批准号:06670196
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1994
-
负责人:YONEZAWA Suguru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Mucin蛋白在泌丝动物家蚕和蜘蛛中的功能研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郭凯雨
-
依托单位:
维生素D受体通过抑制Mucin-1/β1-integrin信号通路调节肠道衰老的相关机制研究
-
批准号:MS25H030029
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:余梦丽
-
依托单位:
肠粘蛋白mucin介导的中肠黏膜屏障在蜜蜂感染囊状幼虫病毒
( SBV )差异性的作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:党晓群
-
依托单位:
黏蛋白1(Mucin1)在脓毒症ALI/ARDS铁死亡发生过程中的作用和机制研究
-
批准号:82300106
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王聿明
-
依托单位:
基于mRNA m5C修饰对PORCN表达水平与核质穿梭的调控探究新型PC/Mucin 涂层促进骨再生的作用机制
-
批准号:82302698
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:白植标
-
依托单位:
Mucin-16/Siglec-10信号调控肿瘤相关巨噬细胞重编程促进胃癌免疫逃逸的作用和机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:徐洁杰
-
依托单位:
Mucin1调节角膜上皮细胞间连接在糖尿病角膜上皮修复中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:陆晓和
-
依托单位:
补气通络胶囊通过外泌体上调Mucin 1及其在骨质疏松性骨折修复中的作用和机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:张顺聪
-
依托单位:
金黄色葡萄球菌调节mucin表达影响鼻黏膜黏液屏障在慢性鼻窦炎发病中的作用及其机制研究
-
批准号:81970857
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:胡华
-
依托单位:
Mucin-1/Wnt/β-catenin通路在高血压肾脏纤维化中的调控作用及机制研究
-
批准号:81970353
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:黄绮芳
-
依托单位: